Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin), By Type, By Action Mechanism (RNA Synthesis Inhibitors, Cell Wall Synthesis Inhibitors), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5主要研究的细节
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Action Mechanism and Type Snapshot
2.3 Drug Class Snapshot
2.4 Competitive Snapshot
Chapter 3 Antibiotics Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Development of advanced products
3.2.1.2 Increasing prevalence of infectious diseases
3.2.1.3 Growing collaborations for development of antibiotics
3.2.2 Market restraint analysis
3.2.2.1大量的专利expirations
3.2.2.2 High R&D cost
3.3 Penetration & Growth Prospect Mapping
3.4 Antibiotics: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
Chapter 4 Antibiotics Market Segment Analysis, By Type, 2018-2030 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Antibiotics Market, by Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Branded Antibiotics
4.5.1.1 Branded market estimates and forecast, 2018-2030 (USD Million)
4.5.2 Generic Antibiotics
4.5.2.1 Generic antibiotics market estimates and forecast, 2018-2030 (USD Million)
Chapter 5 Antibiotics Market Segment Analysis, By Action Mechanism 2018-2030 (USD Million)
5.1 Definition and Scope
5.2 Action Mechanism Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Antibiotics Market, by Action Mechanism, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Cell Wall Synthesis Inhibitors
5.5.1.1 Cell wall synthesis inhibitors market estimates and forecast, 2018 - 2030, (USD Million)
5.5.2 Protein Synthesis Inhibitors
5.5.2.1 Protein synthesis inhibitors market estimates and forecast, 2018 - 2030, (USD Million)
5.5.3 DNA Synthesis Inhibitors
5.5.3.1 DNA synthesis inhibitors estimates and forecast, 2018 - 2030, (USD Million)
5.5.4 RNA Synthesis Inhibitors
5.5.4.1 RNA synthesis inhibitors market estimates and forecast, 2018 - 2030, (USD Million)
5.5.5 Mycolic Acid Inhibitors
5.5.5.1 Mycolic acid inhibitors market estimates and forecast, 2018 - 2030, (USD Million)
5.5.6 Others
5.5.6.1 Others market estimates and forecast, 2018 - 2030, (USD Million)
Chapter 6 Antibiotics Market Segment Analysis, By Drug Class, 2018-2030 (USD Million)
6.1 Definition and Scope
6.2 Drug Class Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Antibiotics Market, by Drug Class, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Cephalosporin
6.5.1.1头孢菌素市场估计和forecast, 2018-2030 (USD Million)
6.5.2 Penicillin
6.5.2.1 Penicillin market estimates and forecast, 2018-2030 (USD Million)
6.5.3 Fluoroquinolone
6.5.3.1 Fluoroquinolone market estimates and forecast, 2018-2030 (USD Million)
6.5.4 Macrolides
6.5.4.1 Macrolides market estimates and forecast, 2018-2030 (USD Million)
6.5.5 Fluoroquinolone
6.5.5.1 Fluoroquinolone market estimates and forecast, 2018-2030 (USD Million)
6.5.6 Carbapenems
6.5.6.1 Carbapenems market estimates and forecast, 2018-2030 (USD Million)
6.5.7 Aminoglycosides
6.5.7.1 Aminoglycosides market estimates and forecast, 2018-2030 (USD Million)
6.5.8 Sulfonamides
6.5.8.1 Sulfonamides market estimates and forecast, 2018-2030 (USD Million)
6.5.9 7-ACA
6.5.9.1 7-ACA market estimates and forecast, 2018-2030 (USD Million)
6.5.10 Others
6.5.10.1 Others market estimates and forecast, 2018-2030 (USD Million)
Chapter 7 Antibiotics Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 SWOT Analysis
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 Middle East & Africa
7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
7.6.1 North America
7.6.1.1北美抗生素市场预期and forecast, 2018-2030 (USD Million)
7.6.1.2 U.S.
7.6.1.2.1 Key Country Dynamics
7.6.1.2.2 Competitive Scenario
7.6.1.2.3 Regulatory Framework
7.6.1.2.4 Reimbursement Scenario
7.6.1.2.5 U.S. antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.1.3 Canada
7.6.1.3.1 Key Country Dynamics
7.6.1.3.2 Competitive Scenario
7.6.1.3.3 Regulatory Framework
7.6.1.3.4 Reimbursement Scenario
7.6.1.3.5 Canada antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.2 Europe
7.6.2.1 Europe antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.2 UK
7.6.2.2.1 Key Country Dynamics
7.6.2.2.2 Competitive Scenario
7.6.2.2.3 Regulatory Framework
7.6.2.2.4 Reimbursement Scenario
7.6.2.2.5 UK antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.2.3 Germany
7.6.2.3.1 Key Country Dynamics
7.6.2.3.2 Competitive Scenario
7.6.2.3.3 Regulatory Framework
7.6.2.23.4 Reimbursement Scenario
7.6.2.3.5 Germany antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.2.4 Spain
7.6.2.4.1 Key Country Dynamics
7.6.2.4.2 Competitive Scenario
7.6.2.4.3 Regulatory Framework
7.6.2.4.4 Reimbursement Scenario
7.6.2.4.5 Spain antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.2.5 France
7.6.2.5.1 Key Country Dynamics
7.6.2.5.2竞争场景
7.6.2.5.3 Regulatory Framework
7.6.2.5.4 Reimbursement Scenario
7.6.2.5.5 France antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.2.6 Italy
7.6.2.6.1 Key Country Dynamics
7.6.2.6.2 Competitive Scenario
7.6.2.6.3 Regulatory Framework
7.6.2.6.4 Reimbursement Scenario
7.6.2.6.5 Italy antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.2.7 Denmark
7.6.2.7.1 Key Country Dynamics
7.6.2.7.2 Competitive Scenario
7.6.2.7.3 Regulatory Framework
7.6.2.7.4 Reimbursement Scenario
7.6.2.7.5 Denmark antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.2.8 Sweden
7.6.2.8.1 Key Country Dynamics
7.6.2.8.2 Competitive Scenario
7.6.2.8.3 Regulatory Framework
7.6.2.8.4 Reimbursement Scenario
7.6.2.8.5 Sweden antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.2.9 Norway
7.6.2.9.1 Key Country Dynamics
7.6.2.9.2 Competitive Scenario
7.6.2.9.3 Regulatory Framework
7.6.2.9.4 Reimbursement Scenario
7.6.2.9.5 Norway antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.3 Asia Pacific
7.6.3.1 Asia Pacific antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3.2 Japan
7.6.3.2.1 Key Country Dynamics
7.6.3.2.2 Competitive Scenario
7.6.3.2.3 Regulatory Framework
7.6.3.2.4 Reimbursement Scenario
7.6.3.2.5 Japan antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.3.3 China
7.6.3.3.1 Key Country Dynamics
7.6.3.3.2 Competitive Scenario
7.6.3.3.3 Regulatory Framework
7.6.3.3.4 Reimbursement Scenario
7.6.3.3.5 China antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.3.4 India
7.6.3.4.1 Key Country Dynamics
7.6.3.4.2 Competitive Scenario
7.6.3.4.3 Regulatory Framework
7.6.3.4.4 Reimbursement Scenario
7.6.3.4.5 India antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.3.5 South Korea
7.6.3.5.1 Key Country Dynamics
7.6.3.5.2 Competitive Scenario
7.6.3.5.3 Regulatory Framework
7.6.3.5.4 Reimbursement Scenario
7.6.3.5.5 South Korea antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.3.6 Australia
7.6.3.6.1 Key Country Dynamics
7.6.3.6.2 Competitive Scenario
7.6.3.6.3 Regulatory Framework
7.6.3.6.4 Reimbursement Scenario
7.6.3.6.5 Australia antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.3.7 Thailand
7.6.3.7.1 Key Country Dynamics
7.6.3.7.2 Competitive Scenario
7.6.3.7.3 Regulatory Framework
7.6.3.7.4 Reimbursement Scenario
7.6.3.7.5 Thailand antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.4 Latin America
7.6.4.1 Latin America antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4.2 Brazil
7.6.4.2.1 Key Country Dynamics
7.6.4.2.2 Competitive Scenario
7.6.4.2.3 Regulatory Framework
7.6.4.2.4 Reimbursement Scenario
7.6.4.2.5 Brazil antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.4.3 Mexico
7.6.4.3.1 Key Country Dynamics
7.6.4.3.2 Competitive Scenario
7.6.4.3.3 Regulatory Framework
7.6.4.3.4 Reimbursement Scenario
7.6.4.3.5 Mexico antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.4.4 Argentina
7.6.4.4.1 Key Country Dynamics
7.6.4.4.2 Competitive Scenario
7.6.4.4.3 Regulatory Framework
7.6.4.4.4 Reimbursement Scenario
7.6.4.4.5 Argentina antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.5 MEA
7.6.5.1 MEA antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5.2 South Africa
7.6.5.2.1 Key Country Dynamics
7.6.5.2.2 Competitive Scenario
7.6.5.2.3 Regulatory Framework
7.6.5.2.4 Reimbursement Scenario
7.6.5.2.5南误判率ica antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.5.3 Saudi Arabia
7.6.5.3.1 Key Country Dynamics
7.6.5.3.2 Competitive Scenario
7.6.5.3.3 Regulatory Framework
7.6.5.3.4 Reimbursement Scenario
7.6.5.3.5 Saudi Arabia antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.5.4 UAE
7.6.5.4.1 Key Country Dynamics
7.6.5.4.2 Competitive Scenario
7.6.5.4.3 Regulatory Framework
7.6.5.4.4 Reimbursement Scenario
7.6.5.4.5 UAE antibiotics market estimates and forecast, 2018-2030 (USD Million)
7.6.5.5 Kuwait
7.6.5.5.1 Key Country Dynamics
7.6.5.5.2 Competitive Scenario
7.6.5.5.3 Regulatory Framework
7.6.5.5.4 Reimbursement Scenario
7.6.5.5.5 Kuwait antibiotics market estimates and forecast, 2018-2030 (USD Million)
Chapter8 Antibiotics Market - Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 Ansoff matrix
8.1.2 Heat map analysis
8.1.3 Major Deals and Strategic Alliances Analysis
8.1.3.1 Joint Ventures
8.1.3.2 Licensing Agreements
8.1.3.3 Product Launches
8.1.3.1 Conferences and Campaigns
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key customers
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.4.1.1 Market Differentiators
8.5 Private Companies
8.5.1 List of key emerging companies
8.6 Company Profiles
8.6.1 Pfizer Inc.
8.6.1.1 Company overview
8.6.1.2 Financial performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic Initiatives
8.6.2 Novartis AG
8.6.2.1 Company overview
8.6.2.2 Financial performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic Initiatives
8.6.3 Merck & Co., Inc.
8.6.3.1 Company overview
8.6.3.2 Financial performance
8.6.3.3 Product benchmarking
8.6.3.4 Strategic Initiatives
8.6.4 Teva Pharmaceutical Industries Ltd.
8.6.4.1 Company overview
8.6.4.2 Financial performance
8.6.4.3 Product benchmarking
8.6.4.4 Strategic Initiatives
8.6.5 Viatris, Inc
8.6.5.1 Company overview
8.6.5.2 Financial performance
8.6.5.3 Product benchmarking
8.6.5.4 Strategic Initiatives
8.6.6 Melinta Therapeutics LLC
8.6.6.1 Company overview
8.6.6.2 Financial performance
8.6.6.3 Product benchmarking
8.6.6.4 Strategic Initiatives
8.6.7 Cipla, Inc
8.6.7.1 Company overview
8.6.7.2 Financial performance
8.6.7.3 Product benchmarking
8.6.7.4 Strategic initiatives
8.6.8 Shionogi & Co., Ltd
8.6.8.1 Company overview
8.6.8.2 Financial performance
8.6.8.3 Product benchmarking
8.6.8.4 Strategic initiatives
8.6.9 KYORIN Pharmaceutical Co., Ltd
8.6.9.1 Company overview
8.6.9.2 Financial performance
8.6.9.3 Product benchmarking
8.6.9.4 Strategic initiatives
8.6.10 GSK plc
8.6.10.1 Company overview
8.6.10.2 Financial performance
8.6.10.3 Product benchmarking
8.6.10.4 Strategic initiatives
8.6.11 AbbVie, Inc.
8.6.11.1 Company overview
8.6.11.2 Financial performance
8.6.11.3 Product benchmarking
8.6.11.4 Strategic initiatives
8.6.12 Lupin Pharmaceuticals, Inc.
8.6.12.1 Company overview
8.6.12.2 Financial performance
8.6.12.3 Product benchmarking
8.6.12.4 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Antibiotics Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 6 Global Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 7 Global Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 8 North America Antibiotics Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 10 North America Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 11 North America Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 12 U.S. Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 13 U.S. Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 14 U.S. Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 15 Canada Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 16 Canada Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 17 Canada Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 18 Europe Antibiotics Market, By Country, 2018 - 2030 (USD Million)
Table 19 Europe Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 20 Europe Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 21 Europe Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 22 UK Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 23 UK Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 24 UK Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 25 Germany Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 26 Germany Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 27 Germany Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 28 France Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 29 France Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 30 France Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 31 Spain Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 32 Spain Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 33 Spain Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 34 Italy Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 35 Italy Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 36 Italy Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 37 Denmark Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 38 Denmark Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 39 Denmark Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 40 Norway Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 41 Norway Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 42 Norway Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 43 Sweden Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 44 Sweden Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 45 Sweden Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Antibiotics Market, By Country, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 50 Japan Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 51 Japan Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 52 Japan Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 53 China Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 54 China Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 55 China Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 56 India Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 57 India Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 58 India Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 59 South Korea Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 60 South Korea Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 61 South Korea Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 62 Australia Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 63 Australia Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 64 Australia Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 65 Thailand Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 66 Thailand Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 67 Thailand Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 68 Latin America Antibiotics Market, By Country, 2018 - 2030 (USD Million)
Table 69 Latin America Antibiotics Market, By Type, 2018 - 2030 (USD Million)
表70年拉丁美洲抗生素市场的活动on Mechanism, 2018 - 2030 (USD Million)
Table 71 Latin America Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 72 Brazil Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 73 Brazil Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 74 Brazil Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 75 Mexico Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 76 Mexico Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 77 Mexico Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 78 Argentina Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 79 Argentina Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 80 Argentina Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 81 Middle East and Africa Antibiotics Market, By Country, 2018 - 2030 (USD Million)
Table 82 Middle East and Africa Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 83 Middle East and Africa Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 84 Middle East and Africa Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 85 South Africa Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 86 South Africa Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 87 South Africa Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 91 UAE Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 92 UAE Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 93 UAE Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 94 Kuwait Antibiotics Market, By Type, 2018 - 2030 (USD Million)
Table 95 Kuwait Antibiotics Market, By Action Mechanism, 2018 - 2030 (USD Million)
Table 96 Kuwait Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Antibiotics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Antibiotics market: Type movement analysis
Fig. 17 Antibiotics market: Type segment dashboard
Fig. 18 Antibiotics market type outlook: Key takeaways
Fig. 19 Branded antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Generic antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Antibiotics market: Drug class movement analysis
Fig. 22 Antibiotics market: Drug class segment dashboard
Fig. 23 Antibiotics market drug class outlook: Key takeaways
Fig. 24 Cephalosporin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Penicillin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Fluoroquinolone market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Macrolides market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Carbapenems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Aminoglycosides market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Sulfonamides market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 7-ACA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Antibiotics market: Action mechanism movement analysis
Fig. 34 Antibiotics market: Action mechanism segment dashboard
Fig. 35 Antibiotics market action mechanism outlook: Key takeaways
Fig. 36 Cell wall synthesis inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Protein synthesis inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 DNA synthesis inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 RNA synthesis inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
图40霉菌酸抑制剂市场预期nd forecast, 2018 - 2030 (USD Million)
Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2022 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional market place: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America antibiotics market, 2018 - 2030 (USD Million)
Fig. 52 U.S. key country dynamics
Fig. 53 U.S. antibiotics market, 2018 - 2030 (USD Million)
Fig. 54 Canada key country dynamics
Fig. 55 Canada antibiotics market, 2018 - 2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe antibiotics market, 2018 - 2030 (USD Million)
Fig. 58 UK key country dynamics
Fig. 59 UK antibiotics market, 2018 - 2030 (USD Million)
Fig. 60 Germany key country dynamics
Fig. 61 Germany antibiotics market, 2018 - 2030 (USD Million)
Fig. 62 Spain key country dynamics
Fig. 63 Spain antibiotics market, 2018 - 2030 (USD Million)
Fig. 64 France key country dynamics
Fig. 65 France antibiotics market, 2018 - 2030 (USD Million)
Fig. 66 Italy key country dynamics
Fig. 67 Italy antibiotics market, 2018 - 2030 (USD Million)
Fig. 68 Denmark key country dynamics
图69年丹麦antibiotics market, 2018 - 2030 (USD Million)
Fig. 70 Norway key country dynamics
Fig. 71 Norway antibiotics market, 2018 - 2030 (USD Million)
Fig. 72 Sweden key country dynamics
Fig. 73 Sweden antibiotics market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific antibiotics market, 2018 - 2030 (USD Million)
Fig. 76 Japan key country dynamics
Fig. 77 Japan antibiotics market, 2018 - 2030 (USD Million)
Fig. 78 China key country dynamics
Fig. 79 China antibiotics market, 2018 - 2030 (USD Million)
Fig. 80 India key country dynamics
Fig. 81 India antibiotics market, 2018 - 2030 (USD Million)
Fig. 82 South Korea key country dynamics
Fig. 83 South Korea antibiotics market, 2018 - 2030 (USD Million)
Fig. 84 Australia key country dynamics
Fig. 85 Australia antibiotics market, 2018 - 2030 (USD Million)
Fig. 86 Thailand key country dynamics
Fig. 87 Thailand antibiotics market, 2018 - 2030 (USD Million)
Fig. 88 Latin America
Fig. 89 Latin America antibiotics market, 2018 - 2030 (USD Million)
Fig. 90 Brazil key country dynamics
Fig. 91 Brazil antibiotics market, 2018 - 2030 (USD Million)
Fig. 92 Mexico key country dynamics
Fig. 93 Mexico antibiotics market, 2018 - 2030 (USD Million)
Fig. 94 Argentina key country dynamics
Fig. 95 Argentina antibiotics market, 2018 - 2030 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA antibiotics market, 2018 - 2030 (USD Million)
Fig. 98 South Africa key country dynamics
Fig. 99 South Africa antibiotics market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia key country dynamics
Fig. 101 Saudi Arabia antibiotics market, 2018 - 2030 (USD Million)
Fig. 102 UAE key country dynamics
Fig. 103 UAE antibiotics market, 2018 - 2030 (USD Million)
Fig. 104 Kuwait key country dynamics
Fig. 105 Kuwait antibiotics market, 2018 - 2030 (USD Million)
Fig. 106 Ansoff matrix
Fig. 107 Heat map analysis
Fig. 108 Market differentiators